<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131225">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02042677</url>
  </required_header>
  <id_info>
    <org_study_id>5566-O</org_study_id>
    <nct_id>NCT02042677</nct_id>
  </id_info>
  <brief_title>Assessment of a Skin Barrier</brief_title>
  <official_title>User Assessment of a One-Piece Skin Barrier</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hollister Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St George's Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North West London Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hollister Incorporated</source>
  <oversight_info>
    <authority>United Kingdom: National Health Service</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This evaluation is being conducted to determine user perception of a new flat one-piece skin
      barrier compared to their normal barrier.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design:

      This is a multi-site, unblinded, historically controlled assessment of a one-piece flat skin
      barrier. Study barriers are CE-marked. Approximately 30 subjects are enrolled in the UK.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>barrier adhesion</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire will be provided to subject to assess barrier adhesion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>barrier tack</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire will be provided to subject to assess barrier tack.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>comfort</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire will be provided to subject to assess comfort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>leakage</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire will be provided to subject to assess leakage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ease of barrier removal</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire will be provided to subject to assess ease of barrier removal.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ileostomy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Current users of either Dansac flat Nova or NovaLife skin barriers with drainable pouches
        who have an ileostomy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. is at least 18 years of age.

          2. has an ileostomy.

          3. is at least six weeks postoperative.

          4. lives and cares for their stoma independently in the community.

          5. currently uses a Dansac Nova or NovaLife 1-piece flat skin barrier.

          6. currently uses a drainable pouch.

          7. is able to wear a 1-piece flat cut-to-fit 10-55 mm.

          8. Has a peristomal skin irritation score of 2 or less.

          9. is willing to follow the protocol as demonstrated by signing the informed consent and
             who in the opinion  of the investigator is qualified to participate.

        Exclusion Criteria:

          1. has a fistula on or near the stoma.

          2. has been involved in a study involving stoma care with in the last 30 days.

          3. is pregnant or lactating, as determined by interview only.

          4. is undergoing chemotherapy, radiation or steroid therapy.

          5. has an existing medical condition that would compromise their participation in the
             study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Dennis</last_name>
    <role>Principal Investigator</role>
    <affiliation>St.  George's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sarah Varma, Stoma Nurse</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Mark's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Dennis</last_name>
    <phone>020 8725 3916</phone>
    <email>heather.dennis@stgeorges.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire Gough</last_name>
    <phone>020 8725 3916</phone>
    <email>claire.gough@stgeorges.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St. Mark's Hospital</name>
      <address>
        <city>Harrow</city>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Varma</last_name>
      <phone>020 8235 4110</phone>
      <email>sarah.varma@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Sarah Varma, Stoma Nurse</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. George's Hospital</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Dennis</last_name>
      <phone>020 8725 3916</phone>
      <email>heather.dennis@stgeorges.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Claire Gough</last_name>
      <phone>020 8725 3916</phone>
      <email>claire.gough@stgeorges.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Heather Dennis, Stoma Nurse</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 22, 2014</lastchanged_date>
  <firstreceived_date>January 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ileostomy</keyword>
  <keyword>1-piece</keyword>
  <keyword>assessment</keyword>
  <keyword>Nova</keyword>
  <keyword>NovaLife</keyword>
  <keyword>Dansac</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
